WWM
BIIB icon

Willingdon Wealth Management’s Biogen BIIB Stock Holding History

Willingdon Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$158K Buy
+500
New +$152K 0.04% 123

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Willingdon Wealth Management's BIIB Position: Q1 2020 in Review

Willingdon Wealth Management held its Biogen (BIIB) position steady in Q1 2020 at 3,690 shares worth $1.17M. The position accounts for 0.29% of the portfolio, ranked #77.

Willingdon Wealth Management first reported a position in BIIB in Q3 2017 and has held it in 11 quarters since. The position peaked at $1.18M in Q4 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Willingdon Wealth Management held 3,690 shares of Biogen worth $1.17M as of Q1 2020.
  • Willingdon Wealth Management left its Biogen share count unchanged in Q1 2020.
  • Biogen made up 0.29% of Willingdon Wealth Management's portfolio in Q1 2020, its #77 holding.
  • Willingdon Wealth Management first reported a position in Biogen in Q3 2017 and has held it in 11 quarters since.
  • Willingdon Wealth Management's Biogen position peaked at $1.18M in Q4 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.